These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2447995)

  • 1. Indoramin--an effective new drug in the management of bladder outflow obstruction.
    Iacovou JW; Dunn M
    Br J Urol; 1987 Dec; 60(6):526-8. PubMed ID: 2447995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indoramin in the treatment of prostatic bladder outflow obstruction.
    Stott MA; Abrams P
    Br J Urol; 1991 May; 67(5):499-501. PubMed ID: 1710162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentre controlled trial of indoramin in the symptomatic relief of benign prostatic hypertrophy.
    Chow W; Hahn D; Sandhu D; Slaney P; Henshaw R; Das G; Wells P
    Br J Urol; 1990 Jan; 65(1):36-8. PubMed ID: 1690068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Indoramin, an alpha blocker, in functional disorders of the lower urinary tract].
    García Ortiz R; Jara O; Barbera A
    Rev Med Chil; 1985 Jan; 113(1):12-7. PubMed ID: 4081378
    [No Abstract]   [Full Text] [Related]  

  • 5. Do alpha-blockers have a role in lower urinary tract dysfunction in multiple sclerosis?
    O'Riordan JI; Doherty C; Javed M; Brophy D; Hutchinson M; Quinlan D
    J Urol; 1995 Apr; 153(4):1114-6. PubMed ID: 7869476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder outflow tract obstruction and urinary retention from benign prostatic hypertrophy treated by balloon dilatation.
    Gill KP; Machan LS; Allison DJ; Williams G
    Br J Urol; 1989 Dec; 64(6):618-22. PubMed ID: 2483354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind controlled trial of a new alpha-1 blocking drug in the treatment of bladder outflow obstruction.
    Ramsay JW; Scott GI; Whitfield HN
    Br J Urol; 1985 Dec; 57(6):657-9. PubMed ID: 2417649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prazosin in the treatment of prostatic obstruction. A placebo-controlled study.
    Kirby RS; Coppinger SW; Corcoran MO; Chapple CR; Flannigan M; Milroy EJ
    Br J Urol; 1987 Aug; 60(2):136-42. PubMed ID: 2444306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urodynamic effects of alpha-adrenoceptor blockers: a review of clinical trials.
    Kortmann BB; Floratos DL; Kiemeney LA; Wijkstra H; de la Rosette JJ
    Urology; 2003 Jul; 62(1):1-9. PubMed ID: 12837408
    [No Abstract]   [Full Text] [Related]  

  • 10. Is indoramin an effective alternative to prostatectomy?
    Lloyd SN; McMahon A; Muller W; Buckley JF; Deane RF; Kirk D; Kyle KF
    Br J Urol; 1992 Oct; 70(4):408-11. PubMed ID: 1450850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe.
    Chapple CR; Montorsi F; Tammela TL; Wirth M; Koldewijn E; Fernández Fernández E;
    Eur Urol; 2011 Mar; 59(3):342-52. PubMed ID: 21109344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detrusor instability and bladder outflow obstruction. Evidence for a correlation between the severity of obstruction and the presence of instability.
    Cucchi A
    Br J Urol; 1988 May; 61(5):420-2. PubMed ID: 2456120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptomatic treatment of benign prostatic obstruction with nicergoline: a placebo controlled clinical study and urodynamic evaluation.
    Ronchi F; Margonato A; Ceccardi R; Rigatti P; Rossini BM
    Urol Res; 1982; 10(3):131-4. PubMed ID: 6182672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A three month double-blind study of doxazosin as treatment for benign prostatic bladder outlet obstruction.
    Chapple CR; Carter P; Christmas TJ; Kirby RS; Bryan J; Milroy EJ; Abrams P
    Br J Urol; 1994 Jul; 74(1):50-6. PubMed ID: 7519112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of transrectal ultrasonographic findings of the prostate with the occurrence of detrusor instability in patients with benign prostatic hyperplasia.
    Tong YC; Lin YM; Yang WH; Tzai TS; Lin JS
    Urol Int; 1995; 55(3):154-7. PubMed ID: 8540161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benign prostatic hyperplasia (BHP) and bothersome voiding symptoms.
    Hald T
    J Urol (Paris); 1995; 101(1):7-9. PubMed ID: 7545735
    [No Abstract]   [Full Text] [Related]  

  • 17. Male lower urinary tract symptoms: treatment with a-blockers, 5-a-reductase inhibitors, antimuscarinics, or a combination.
    Appell RA
    Curr Urol Rep; 2007 Sep; 8(5):370-2. PubMed ID: 17880835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of prazosin HCl on micturition disturbance associated with benign prostatic hypertrophy and bladder neck contracture.
    Kohama Y; Watanabe H; Sen Y; Yamamoto Y; Morioka M; Fujita Y
    Urol Int; 1990; 45 Suppl 1():26-9. PubMed ID: 1690477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in parameters before and after alpha-1-blocker therapy for men with lower urinary tract symptoms using color doppler ultrasound urodynamics: possible application for prediction of clinical outcome.
    Watanabe Y; Yokoyama T; Ozawa H; Nishiguchi J; Nose H; Kumon H
    Urol Int; 2004; 73(3):252-7. PubMed ID: 15539846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of transurethral needle ablation of the prostate for symptomatic outlet obstruction.
    Rosario DJ; Woo H; Potts KL; Cutinha PE; Hastie KJ; Chapple CR
    Br J Urol; 1997 Oct; 80(4):579-86. PubMed ID: 9352697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.